Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: blood loss (228), haemorrhage (88), flow (235)

FC PO (5 day)-Cyclophosphamide-Fludarabine PO 5 day Ver 1.1

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-FLUDARABINE ORAL 5 DAY (FC PO 5 day) Regimen Lymphoma – FC PO (5 day)-Cyclophosphamide-Fludarabine PO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/FC-PO-5-day-Cyclophosphamide-Fludarabine-PO-5-day-Ver-1.1.pdf

Cyclophosphamide-Etoposide PO Ver 1.1

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-ETOPOSIDE ORAL Regimen Lymphoma – Cyclophosphamide-Etoposide PO Indication Palliative treatment of malignant lymphoma Toxicity Drug Adverse Effect
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Cyclophosphamide-Etoposide-PO-Ver-1.1.pdf

CVP-Cyclophosphamide-Prednisolone-Vincristine Ver 1.2

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-PREDNISOLONE-VINCRISTINE (CVP) Regimen Lymphoma – CVP-Cyclophosphamide-Prednisolone-Vincristine Indication Non Hodgkin’s Lymphoma Toxicity Drug Adverse
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CVP-Cyclophosphamide-Prednisolone-Vincristine-Ver-1.2.pdf

Paclitaxel (14day)

Description: Chemotherapy Protocol SARCOMA PACLITAXEL (14 day) Regimen • Sarcoma – Paclitaxel (14 day) Indication • Second line treatment of Kaposi sarcoma • WHO Performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Paclitaxel14day.pdf

Irinotecan-Temozolomide

Description: Chemotherapy Protocol Sarcoma IRINOTECAN - TEMOZOLOMIDE Regimen • Sarcoma – Irinotecan-Temozolomide Indication • Recurrent or progressive Ewings sarcoma • Performance status 0, 1, 2 Toxicity
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Irinotecan-Temozolomide.pdf

InPEtoposideIfosfamide(5dy)Ver1

Description: Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 day) Inpatient Regimen Regimen Sarcoma-InP-Etoposide-Ifosfamide (5 day) Indication Second line treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPEtoposideIfosfamide5dyVer1.pdf

InP Ifosfamide(2day)Ver1

Description: Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day) Indication Advanced or metastatic soft tissue sarcoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

Cyclophosphamide-Dactinomycin-Vincristine (VAC) v1

Description: Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-DACTINOMYCIN-VINCRISTINE (VAC) Regimen Sarcoma-Cyclophosphamide-Dactinomycin-Vincristine (VAC) Indication Ewings Sarcoma Toxicity Drug Cyclophosphamide Dactinomycin Vincristine
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Dactinomycin-Vincristine-VAC-v1.pdf

InP-Cisplatin-Fluorouracil

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN-FLUOROURACIL In-Patient Regimen Regimen • Head and Neck Cancer – InP-Cisplatin-Fluorouracil Indication • Neoadjuvant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/InP-Cisplatin-Fluorouracil.pdf

Cisplatin-Fluorouracil

Description: Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN-FLUOROURACIL Regimen • Head and Neck Cancer – Cisplatin-Fluorouracil Indication • Neoadjuvant and palliative treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-Fluorouracil.pdf

321 to 330 of 705

Previous … 31 32 33 34 35 … Next